Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation-Reference-Cited by-同舟云学术

Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation

Published:2012-01 Issue:1 Volume:133 Page:91-98
ISSN:0001-6489
Container-title:Acta Oto-Laryngologica
language:en
Short-container-title:Acta Oto-Laryngologica

Author:

Furusaka Tohru,Susaki Yasuhiko,Saito Tsutomu,Katsura Yoshihisa,Ikeda Minoru

Publisher

Informa UK Limited

Subject

Otorhinolaryngology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/00016489.2012.715372

Reference20 articles.

1. Long-term observations and salvage operations on patients with T2N0M0 squamous cell carcinoma of the glottic larynx treated with radiation therapy alone

2. Sobin LH, Gospodarowicsz MK, Wittekind Ch. 2009. TNM classification of malignant tumours. 7th edition. New York: John Wiley & Sons. p 39–45.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncological outcomes of surgical management for T2N0M0 glottic laryngeal squamous cell carcinoma;World Journal of Otorhinolaryngology - Head and Neck Surgery;2024-03-31

2. Oncological outcomes of surgical management for T2N0M0 glottic laryngeal squamous cell carcinoma;2023-04-13

3. Meta-Analysis of Low Temperature Plasma Radiofrequency Ablation and CO2 Laser Surgery on Early Glottic Laryngeal Carcinoma;Computational and Mathematical Methods in Medicine;2022-07-06

4. Laryngectomy-free survival after salvage partial laryngectomy: a systematic review and meta-analysis;European Archives of Oto-Rhino-Laryngology;2022-01-17

5. Could Primary Chemoradiotherapy in T2 Glottic Cancers Yield Results Comparable to Primary Radiotherapy in T1? Considerations from 531 German Early Stage Patients;Cancers;2021-03-31